Mats Jerkeman
61 – 70 of 203
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Myocardial infarction in diffuse large B-cell lymphoma patients – a population-based matched cohort study
- Contribution to journal › Article
-
Mark
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma : Recommendations for the Second Phase of the COVID-19 Pandemic
- Contribution to journal › Scientific review
-
Mark
Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival
- Contribution to journal › Article
-
Mark
Detailed Long-Term Follow-Up of Patients Who Relapsed after the Nordic Mantle Cell Lymphoma Trials : MCL2 and MCL3
- Contribution to journal › Article
-
Mark
How should we use ibrutinib in patients with mantle cell lymphoma?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Detecting deviations from the efficacy and safety results of single-arm trials using real-world data : The case of a CAR-T cell therapy in B-cell lymphoma
(2021) In Pharmacoepidemiology and Drug Safety
- Contribution to journal › Article
-
Mark
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors
- Contribution to journal › Article
-
Mark
Clinical characteristics and histopathological patterns of hodgkin lymphoma and treatment outcomes at a tertiary cancer center in ethiopia
- Contribution to journal › Article
-
Mark
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets
- Contribution to journal › Article
-
Mark
Association between anthropometry and lifestyle factors and risk of B-cell lymphoma : An exposome-wide analysis
- Contribution to journal › Article
